MBBS, MRCP, FRCPath, MD
"I specialise in haemato-oncology and general haematology including haemostasis, thrombosis, haemoglobinopathy and obstetric haematology."
I specialise in haemato-oncology and general haematology including haemostasis, thrombosis, haemoglobinopathy and obstetric haematology, having trained at Hammersmith Hospital, London and completed a fellowship in cancer studies at Imperial College, London. I have published in peer reviewed journals and authored chapters in haemato-oncology.
I am specialist in adult haemato-oncology covering all malignant haematological conditions and general haematology including haemostasis, thrombosis, obstetric haematology and; Anaemia, low white cell count, polycythaemia and thrombocytopenia; Investigation of abnormal/raised white cell counts; Chronic leukaemia including CML(chronic myeloid leukaemia), CLL(chronic lymphocytic leukaemia), HCL (hairy cell leukaemia); Abnormal bleeding or bruising; Thromboembolism and investigation into causes, anticoagulation, including using DOACs; Paraproteinemias and abnormal light chains; Unexplained symptoms with abnormal blood counts; Pregnancy and haematology; Enlarged lymph nodes, with or without weight loss, sweats; Persistent unexplained fever, fatigue.
Some of the principal treatments carried out by Dr Pratap Neelakantan at Spire include:
COVID-19 testing or antibody tests are not available as a standalone service at Spire Dunedin Hospital.
Royal College of pathologists
British Society of haematology
Clinical lead for myeloma, CML and MPN at Royal Berkshire Hospital
Currently, clinical lead for myeloma, CML and MPN at Royal Berkshire Hospital. Actively involved in clinical trials.
Honorary contract with Oxford university hospitals and involved in national trials on myeloproliferative neoplasms.